MiR-4689 has been reported to effectively inhibit Kirsten rat sarcoma virus (KRAS)-driven epidermal growth factor receptor (EGFR) signaling by directly inhibiting KRAS and AKT1 in colorectal cancer cells [14]. The gene discussed is EGFR; the disease is colorectal cancer.